Natland sold the company to Inferity Management

18.11.2023

Investment group Natland has agreed with the management of the Inferity group, which includes Anygence and the AnyCare brand, to buy a minority stake of 20%. Jakub Schůrek, CEO and managing director of Inferity, now holds 85% of the company through MKJS Union s.r.o. together with Michal Krobot. The remaining shares were retained by the three original shareholders. For Natland, Inferity is another example of a successful management buy-out. The companies also agreed not to comment on the size of the transaction.

Natland originally joined Anygence in 2020 to help increase testing capacity for covid-19 disease in the Czech Republic. In 2021, Anygence merged with healthcare data processing start-up Aiolite to form Inferity.

Inferity is a group of companies providing services and products for the future of digitally-oriented healthcare, focused directly on healthcare at home or at work, its technology also helps doctors directly at the patient’s bedside. It combines standard healthcare modalities with hi-tech diagnostics and with modern AI-based approaches for data handling and telemedicine.

As a financial investor, Natland Group always cooperates with company managements in its equity holdings; the buyers of its shares are usually strategic or financial investors. In more than one fifth of cases, however, the sale is made in the form of a management buy-out and the new owners are the company managers. Recent examples include Cognito and SCF Servis.

Back